2008 March 31st
Base4innovation is pleased to announce the
appointment of John Sulston, former Director of the Wellcome Trust Sanger
Institute
and Nobel Laureate, to the Board of Advisors. His guidance in the planning
and ethics of sequencing projects, as well as in the structuring of
larger-scale projects will be invaluable.
2008 March 1st
It is with great pleasure that we welcome experienced biotech entrepreneur David Oxlade to base4innovation as Chairman of the Board of Directors. David Oxlade is an experienced health care business executive; until recently a Director and Chief Executive of Xenova Group plc, David is also a Non-Executive Director of Cobra Biomanufacturing plc. During his career, David has been involved in the development of a number of public and private innovative healthcare businesses in Europe, North America and Asia. Prior to joining the Xenova Group, David held managerial and Board level positions with several international and global companies, including that of President of Syva Company, the California based subsidiary of Hoechst AG, ICI Diagnostics, Boehringer Mannheim GmbH (now part of Roche) and Glaxo Research.
- 2007: October 10 The X PRIZE Foundation Announces First International Competitor for Genome Sequencing Prize
- 2007: May 3 The X PRIZE Foundation Announces New Competitor for Pioneering Genome Sequencing Prize
- 2007: April 17 The X PRIZE Foundation Announces New Member of Scientific Advisory Board for Genomics Prize
- 2007: March 13 X PRIZE Taps Marc Hodosh to lead $10 Million Genomics Competition
- 2006: October 4 X PRIZE Foundation Announces Largest Medical Prize in History
